133 related articles for article (PubMed ID: 17507796)
1. Exploiting the TRIP-Br family of cell cycle regulatory proteins as chemotherapeutic drug targets in human cancer.
Zang ZJ; Sim KG; Cheong JK; Yang CM; Yap CS; Hsu SI
Cancer Biol Ther; 2007 May; 6(5):712-8. PubMed ID: 17507796
[TBL] [Abstract][Full Text] [Related]
2. TRIP-Br links E2F to novel functions in the regulation of cyclin E expression during cell cycle progression and in the maintenance of genomic stability.
Sim KG; Zang Z; Yang CM; Bonventre JV; Hsu SI
Cell Cycle; 2004 Oct; 3(10):1296-304. PubMed ID: 15467469
[TBL] [Abstract][Full Text] [Related]
3. TRIP-Br: a novel family of PHD zinc finger- and bromodomain-interacting proteins that regulate the transcriptional activity of E2F-1/DP-1.
Hsu SI; Yang CM; Sim KG; Hentschel DM; O'Leary E; Bonventre JV
EMBO J; 2001 May; 20(9):2273-85. PubMed ID: 11331592
[TBL] [Abstract][Full Text] [Related]
4. The human papillomavirus type 11 and 16 E6 proteins modulate the cell-cycle regulator and transcription cofactor TRIP-Br1.
Gupta S; Takhar PP; Degenkolbe R; Koh CH; Zimmermann H; Yang CM; Guan Sim K; Hsu SI; Bernard HU
Virology; 2003 Dec; 317(1):155-64. PubMed ID: 14675634
[TBL] [Abstract][Full Text] [Related]
5. The TRIP-Br family of transcriptional regulators is essential for the execution of cyclin E-mediated cell cycle progression.
Sim KG; Cheong JK; Hsu SI
Cell Cycle; 2006 May; 5(10):1111-5. PubMed ID: 16721052
[TBL] [Abstract][Full Text] [Related]
6. Identification of PP2A as a novel interactor and regulator of TRIP-Br1.
Zang ZJ; Gunaratnam L; Cheong JK; Lai LY; Hsiao LL; O'Leary E; Sun X; Salto-Tellez M; Bonventre JV; Hsu SI
Cell Signal; 2009 Jan; 21(1):34-42. PubMed ID: 18940248
[TBL] [Abstract][Full Text] [Related]
7. TRIP-Br2 promotes oncogenesis in nude mice and is frequently overexpressed in multiple human tumors.
Cheong JK; Gunaratnam L; Zang ZJ; Yang CM; Sun X; Nasr SL; Sim KG; Peh BK; Rashid SB; Bonventre JV; Salto-Tellez M; Hsu SI
J Transl Med; 2009 Jan; 7():8. PubMed ID: 19152710
[TBL] [Abstract][Full Text] [Related]
8. The soybean-derived peptide lunasin inhibits non-small cell lung cancer cell proliferation by suppressing phosphorylation of the retinoblastoma protein.
McConnell EJ; Devapatla B; Yaddanapudi K; Davis KR
Oncotarget; 2015 Mar; 6(7):4649-62. PubMed ID: 25609198
[TBL] [Abstract][Full Text] [Related]
9. TRIP-Br1 oncoprotein inhibits autophagy, apoptosis, and necroptosis under nutrient/serum-deprived condition.
Jung S; Li C; Duan J; Lee S; Kim K; Park Y; Yang Y; Kim KI; Lim JS; Cheon CI; Kang YS; Lee MS
Oncotarget; 2015 Oct; 6(30):29060-75. PubMed ID: 26334958
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
Zhang X; Zhang J; Wang L; Wei H; Tian Z
BMC Cancer; 2007 Aug; 7():149. PubMed ID: 17683579
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional and subcellular regulation of the TRIP-Br family.
Lai IL; Wang SY; Yao YL; Yang WM
Gene; 2007 Feb; 388(1-2):102-9. PubMed ID: 17141982
[TBL] [Abstract][Full Text] [Related]
12. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
[TBL] [Abstract][Full Text] [Related]
13. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
14. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory role of TRIP-Br1 oncoprotein in hypoxia-induced apoptosis in breast cancer cell lines.
Li C; Jung S; Yang Y; Kim KI; Lim JS; Cheon CI; Lee MS
Int J Oncol; 2016 Jun; 48(6):2639-46. PubMed ID: 27035851
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of HMGN5 suppresses the viability and invasion of human urothelial bladder cancer 5637 cells in vitro and in vivo.
Gan Y; Tan J; Yang J; Zhou Y; Dai Y; He L; Yao K; Tang Y
Med Oncol; 2015 Apr; 32(4):136. PubMed ID: 25796505
[TBL] [Abstract][Full Text] [Related]
17. [Antitumor effect and mechanism of shikonin derivative SYUNZ-7].
Huang H; Xie BF; Zhu XF; Feng GK; Zhou JM; Wang Y; Wu HQ; Huang ZS; Gu LQ; Liu ZC
Ai Zheng; 2005 Dec; 24(12):1453-8. PubMed ID: 16351791
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of decoy oligodeoxynucleotides targeted to NF-kappaB in vitro and in vivo.
Wang T; Li QH; Hao GP; Zhai J
Asian Pac J Cancer Prev; 2010; 11(1):193-200. PubMed ID: 20593956
[TBL] [Abstract][Full Text] [Related]
19. A novel polysaccharide, isolated from Angelica sinensis (Oliv.) Diels induces the apoptosis of cervical cancer HeLa cells through an intrinsic apoptotic pathway.
Cao W; Li XQ; Wang X; Fan HT; Zhang XN; Hou Y; Liu SB; Mei QB
Phytomedicine; 2010 Jul; 17(8-9):598-605. PubMed ID: 20092988
[TBL] [Abstract][Full Text] [Related]
20. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
